Pacific Edge shares more than double on US healthcare news

Pacific Edge shares more than double on US healthcare news
Brent Melville
Pacific Edge shares more than doubled in value on confirmation of acceptance under a key US medical regulation for its Cxbladder cancer test. The shares jumped as high as 68 cents from 27 cents yesterday, and were recently at 55 cents, up 104 percent and valuing the company at $379.3 million. The successful standard of care rating from the US Centres for Medicare and Medicaid Services means Pacific Edge will be reimbursed at a rate of US$760 per test from July 1, 2020.  The CMS provides healthcare coverage for all US citizens over the...

More Services

Auckland accountancy snapped up by Hong Kong firm Acclime
Services

Auckland accountancy snapped up by Hong Kong firm Acclime

It is the second Auckland firm Acclime has acquired in as many years.

John Anthony 11 Apr 2025
Engineering firms lose 1200 people in a year
Services

Engineering firms lose 1200 people in a year

But despite the job numbers, most firms were optimistic about the sector’s prospects.

Staff reporters 09 Apr 2025
Former school lunch provider in liquidation
Law & Regulation

Former school lunch provider in liquidation

Secret Chef stopped trading in December last year.

Michael Neilson 18 Mar 2025
Libelle approached liquidators late last week
Services Exclusive

Libelle approached liquidators late last week

Liquidators were called on the same day a student was burned by a meal.

Cécile Meier 11 Mar 2025